Replies to post #37393 on Pharmagen Inc (PHRX)

[THEBELGIAN77]

Not agree with that.
People and market makers should see an increase of value through this PR. We are going to see if they put the money on the table.
Products, FDA registration, decreasing debt, and new cash, what would you want more?
Just my thoughts.

[lawdog1]

TO OUR SHAREHOLDERS:


You are cordially invited to attend the 2013 Annual Meeting of the Shareholders of Pharmagen, Inc. (the “Company”) to be held on Monday, February 24, 2014, at 10:00 AM, Eastern Standard Time, at our sales office located at 2413 Linden Lane, Silver Spring, MD 20910, to consider and act upon the following proposals, as described in the accompanying Proxy Statement:


1. To elect two (2) directors to serve until the next Annual Meeting of Shareholders and thereafter until their successor(s) are elected and qualified;

2. To amend to the Articles of Incorporation of the Company to increase the authorized common stock to one billion (1,000,000,000) shares;

3. To approve an amendment to the Articles of Incorporation of the Company to effectuate a reverse split of the Company’s common stock, in an amount to be determined at a future date by the Board of Directors of the Company up to 1-for-30, and to simultaneously decrease the authorized common stock to one hundred million (100,000,000) shares, all to be effectuated at a future date as determined by the Board of Directors of the Company;

4. To approve the Pharmagen, Inc. 2014 Employee Securities Plan;

5. To approve the Pharmagen, Inc. 2014 Officer and Director Securities Plan;

6. To ratify the appointment of M&K CPAS, PLLC, as independent auditors of the Company’s financial statements for the fiscal year ended December 31, 2013; and

7. To transact such other business as may properly come before the meeting or any adjournments thereof.